PremiumSMMT

Summit Therapeutics: insider purchases totaling $11 million

Two CEOs and a key director at the biotechnology company made insider purchases totaling $11 million.

By the SpyStocks desk · 10mo ago · 1 min read

Related Stories

Major move at Somnigroup International: CEO buys shares for almost $2 million one day after major deal completion

PremiumInsidersSGI1d ago3 min read

Will Pfizer do a Moderna for investors?

PremiumInsidersPFE2d ago4 min read

Intriguing activity in Madison Air

PremiumInsidersMAIR2d ago3 min read